Tobacco Use and Periodontal Disease—The Role of Microvascular Dysfunction

Abstract

Periodontal disease consists in highly prevalent wide-ranging inflammatory conditions that affect the supporting apparatus of teeth. Tobacco use is the most important risk factor for periodontal disease as it increases disease severity and periodontal surgery complications. Tobacco use is harmful for the vasculature by causing microvascular dysfunction, which is known to negatively affect periodontal disease. To the author’s knowledge this paper is the first comprehensive review on the mechanisms by which tobacco use affects oral microcirculation and impacts the pathophysiology of periodontal disease. In healthy subjects, acute nicotine administration or tobacco use (smoking/smokeless forms) increases the blood flow in the oral mucosa due to local irritation and increased blood pressure, which overcome neural- and endocrine-mediated vasoconstriction. Chronic tobacco smokers display an increased gingival microvascular density, which is attributed to an increased capillary recruitment, however, these microcirculatory units show higher tortuosity and lower caliber. These morphological changes, together with the repetitive vasoconstrictive insults, contribute to lower gingival perfusion in chronic smokers and do not completely regress upon smoking cessation. In periodontal disease there is considerable gingival inflammation and angiogenesis in non-smokers which, in chronic smokers, are considerably suppressed, in part due to local immune suppression and oxidative stress. Tobacco exposure, irrespective of the form of use, causes long-term microvascular dysfunction that increases the risk of complications due to the natural disease course or secondary therapeutic strategies.

Ancient herpes simplex 1 genomes reveal recent viral structure in Eurasia

“…HSV-1 has been found at higher prevalence in cases of chronic and aggressive periodontitis ( 30 ), although its role in pathogenesis is inconclusive ( 30 ). The skeletons of both EDI111 and JDS005 have dental pathology consistent with periodontal disease, and RIJ001 was a tobacco smoker (Supplementary Materials), which is a major risk factor for periodontitis [reviewed in ( 31 )]. Metagenomic screening of our tooth root libraries identified the presence of sequences commonly associated with periodontal pathogens in EDI111 and RIJ001 ( Fig.…”

Prevalence and predictors of dyslipidemia among hypertensive patients in Lumame Primary Hospital, Amhara, Ethiopia: A cross-sectional study

“…Although the mechanisms by which cigarette smoking changes lipoprotein and serum lipid levels are not fully understood, possible explanations have been proposed. The nicotine stimulates the secretion of catecholamines as well as other hormones such as growth hormones and cortisol, leading to an increased serum concentration of free fatty acids which stimulates hepatic secretion of triglycerides and very low density lipoprotein [ 71 ]. Consistent with the previous study, current smoking and drinking increase the risk of dyslipidemia in hypertensive population [ 61 ].…”

Partial Synthetic PPARƳ Derivative Ameliorates Aorta Injury in Experimental Diabetic Rats Mediated by Activation of miR-126-5p Pi3k/AKT/PDK 1/mTOR Expression

“…Moreover, severe endothelium smooth muscle histological abnormalities were evidenced by endothelial lining clefts with cytoplasmic vacuoles in smooth muscle proliferation, as well as eNOS in the smooth muscle ( Figure 5 A,B and Figure 6 A,B).In agreement with our data results, previous studies revealed that STZ-induced DM endothelial complications in the experimental rats significantly increased tissue levels of VIP, E-selectin, endothelin-1, and ICAM-1 [ 86 , 87 ]. Additionally, earlier data proved that vascular damage is induced as a secondary complication to metabolic syndrome-induced insulin resistance in diabetic patients [ 88 ], enhancing immunological disorders [ 89 , 90 ]. Consequently, endothelial damage triggers systemic inflammation by increasing the production of proinflammatory molecules and vasoconstrictor agents such as VIP, E-selectin, endothelin-1, and ICAM-1 [ 91 , 92 ], together with an imbalance between endothelial eNOS and iNOS [ 93 , 94 ].…”